APA (7th ed.) Citation

Deng, S., Zhao, H., Chai, S., Sun, Y., Shen, P., Lin, H., & Zhan, S. (2024). Influence of early use of sodium-glucose transport protein 2 inhibitors, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on the legacy effect of hyperglycemia. Frontiers in endocrinology (Lausanne), 15, 1369908. https://doi.org/10.3389/fendo.2024.1369908

Chicago Style (17th ed.) Citation

Deng, Siwei, Houyu Zhao, Sanbao Chai, Yexiang Sun, Peng Shen, Hongbo Lin, and Siyan Zhan. "Influence of Early Use of Sodium-glucose Transport Protein 2 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors on the Legacy Effect of Hyperglycemia." Frontiers in Endocrinology (Lausanne) 15 (2024): 1369908. https://doi.org/10.3389/fendo.2024.1369908.

MLA (9th ed.) Citation

Deng, Siwei, et al. "Influence of Early Use of Sodium-glucose Transport Protein 2 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors on the Legacy Effect of Hyperglycemia." Frontiers in Endocrinology (Lausanne), vol. 15, 2024, p. 1369908, https://doi.org/10.3389/fendo.2024.1369908.